Diagnostic and management roles of FDG PET/CT imaging in post‐transplant lympho‐proliferation in pediatric heart transplantation
- 26 May 2023
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 37 (9) , e15015
Abstract
Post-transplant lymphoproliferative disorder (PTLD) is a serious complication of pediatric heart transplant (PHTx). 18F-FDG PET/CT has been used to differentiate early lympho-proliferation from more advanced PTLD. We report our experience with PET/CT in the management of PTLD following PHTx. This was a retrospective study of 100 consecutive PHTx recipients at our institution between 2004 and 2018. Patients who underwent PET/CT or conventional CT scans to evaluate for PTLD or high Epstein-Barr viral load were included. Males, eight females. Median age at transplant was 3.5 months (IQR = 1.5-27.5). Median age at PTLD diagnosis was 13.3 years (IQR = 9.2-16.1). Median time between transplant and PTLD diagnosis was 9.5 (IQR = 4.5-15) years. Induction agents were used in 12 patients (50%): Thymoglobulin (N = 9), anti-IL2 (N = 2), and Rituximab (N = 1). Eighteen patients (75%) had PET/CT, of whom 14 had 18FDG-avid PTLD. Six had conventional CT. Nineteen patients (79.2%) had diagnostic biopsy confirmation of PTLD, and 5 (20.8%) had excisional biopsies. Two patients had Hodgkin's lymphoma; nine had monomorphic PTLD; eight had polymorphic PTLD; five were classified as other. Nine patients had monomorphic PTLD, including seven with diffuse large cell lymphoma (DLBC) and one with T cell lymphoma. The majority (16/24) had multi-site involvement at PTLD diagnosis, and PET/CT showed that 31.3% (5/16) had easily accessible subcutaneous nodes. Seventeen patients (overall survival 71%) underwent successful treatment without recurrence of PTLD. Of seven deaths (7/24, 29%), five had DLBC lymphoma, one had polymorphic PTLD and one had T-cell lymphoma. PET-CT allowed simultaneous anatomical and functional assessment of PTLD lesions, while guiding biopsy. In patients with multiple lesions, PET/CT revealed the most prominent and active lesions, improving diagnostic accuracy.Keywords
This publication has 13 references indexed in Scilit:
- The value of 18F‐FDG PET in pediatric patients with post‐transplant lymphoproliferative disorder at initial diagnosisPediatric Transplantation, 2015
- Contribution of 18fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseasesMedecine Et Maladies Infectieuses, 2014
- De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yrClinical Transplantation, 2012
- The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorderHaematologica, 2012
- New concepts and best practices for management of pre- and post-transplantation cancerTransplantation Reviews, 2012
- Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective reviewPediatric Radiology, 2009
- Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: A possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoringEuropean Journal of Radiology, 2007
- PET and PET/CT in Pediatric OncologySeminars in Nuclear Medicine, 2007
- PET/CT and SPECT/CT Dosimetry in Children: The Challenge to the Pediatric ImagerSeminars in Nuclear Medicine, 2007
- FDG-PET/CT in re-staging of patients with lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003